ProQR Therapeutics N.V.

PRQR

$1.47

Name : ProQR Therapeutics N.V.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $154,882,960.00

EPSttm : -0.48

ProQR Therapeutics N.V.

$1.47

3.92%

$0.06

PRQR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.21

Margin Of Safety %

Put/Call OI Ratio

0.01

EPS Next Q Diff

0.01

EPS Last/This Y

-0.15

EPS This/Next Y

-0.06

Price

1.47

Target Price

8.95

Analyst Recom

Performance Q

-18.33

Upside

-542.2%

Beta

0.08

Ticker: PRQR

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	PRQR	1.615	0.02	0.00	430
2026-05-12	PRQR	1.61	0.02	0.00	430
2026-05-13	PRQR	1.71	0.02	0.00	430
2026-05-14	PRQR	1.66	0.02	0.00	430
2026-05-15	PRQR	1.6	0.01	0.00	448
2026-05-18	PRQR	1.515	0.01	0.00	448
2026-05-19	PRQR	1.435	0.01	0.00	375
2026-05-20	PRQR	1.43	0.01	0.00	375
2026-05-21	PRQR	1.43	0.01	0.00	375
2026-05-22	PRQR	1.555	0.01	0.00	375
2026-05-26	PRQR	1.57	0.01	0.00	375
2026-05-27	PRQR	1.57	0.01	0.00	377
2026-05-28	PRQR	1.58	0.01	0.00	379
2026-05-29	PRQR	1.59	0.01	0.00	380
2026-06-02	PRQR	1.48	0.01	0.00	382
2026-06-03	PRQR	1.475	0.01	0.00	432
2026-06-04	PRQR	1.535	0.01	0.00	452
2026-06-05	PRQR	1.51	0.01	0.00	452
2026-06-08	PRQR	1.54	0.01	0.00	477
2026-06-09	PRQR	1.475	0.01	0.00	477
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	PRQR	1.62	-58.6	-	-0.58
2026-05-12	PRQR	1.61	-58.6	-	-0.58
2026-05-13	PRQR	1.71	-58.6	-	-0.58
2026-05-14	PRQR	1.65	-58.6	-	-0.58
2026-05-15	PRQR	1.59	-58.6	-	-0.58
2026-05-18	PRQR	1.51	-	-	-0.58
2026-05-19	PRQR	1.43	-	-	-0.58
2026-05-20	PRQR	1.43	-	-	-0.58
2026-05-21	PRQR	1.44	-	-	-0.58
2026-05-22	PRQR	1.55	-	-	-0.62
2026-05-26	PRQR	1.58	-	-	-0.62
2026-05-27	PRQR	1.58	-	-	-0.62
2026-05-28	PRQR	1.57	-	-	-0.62
2026-05-29	PRQR	1.59	-	-	-0.62
2026-06-01	PRQR	1.42	-	-	-0.62
2026-06-02	PRQR	1.49	-	-	-0.62
2026-06-03	PRQR	1.48	-	-	-0.62
2026-06-04	PRQR	1.54	-	-	-0.62
2026-06-05	PRQR	1.50	-	-	-0.62
2026-06-08	PRQR	1.53	-	-	-0.62
2026-06-09	PRQR	1.47	-	-	-0.62
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	PRQR	0.00	-1.04	1.77
2026-05-12	PRQR	0.00	-1.04	1.18
2026-05-13	PRQR	0.00	-1.04	1.18
2026-05-14	PRQR	0.00	-1.04	1.18
2026-05-15	PRQR	0.00	-1.04	1.18
2026-05-18	PRQR	0.00	-0.86	1.18
2026-05-19	PRQR	0.00	-0.86	1.18
2026-05-20	PRQR	0.00	-0.86	1.18
2026-05-21	PRQR	0.00	-0.86	1.18
2026-05-22	PRQR	0.00	-0.86	1.18
2026-05-26	PRQR	0.00	-2.10	1.18
2026-05-27	PRQR	0.00	-2.10	1.18
2026-05-28	PRQR	0.00	-2.10	1.21
2026-05-29	PRQR	0.00	-2.10	1.21
2026-06-02	PRQR	0.00	-2.07	1.21
2026-06-03	PRQR	0.00	-2.07	1.21
2026-06-04	PRQR	0.00	-2.07	1.21
2026-06-05	PRQR	0.00	-2.07	1.21
2026-06-08	PRQR	0.00	-2.07	1.21
2026-06-09	PRQR	0.00	-2.07	1.21
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.15

Avg. EPS Est. Current Quarter

-0.19

Avg. EPS Est. Next Quarter

-0.14

Insider Transactions

Institutional Transactions

-2.07

Beta

0.08

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

83.8

Max Drawdown 5-Year %

-93.4

Target Price

8.95

P/E

Forward P/E

PEG

P/S

9.97

P/B

3.58

P/Free Cash Flow

EPS

-0.5

Average EPS Est. Cur. Y

-0.62

EPS Next Y. (Est.)

-0.68

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-339.39

Relative Volume

0.78

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.62

EBIT Estimation

◆ PRQR Healthcare

$1.47

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

13/25

Volume

9/15

Valuation

12/20

TP/AR

2/10

Options

5/10

RSI

43.9

Range 1M

30.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

4/30

Estimates

0/20

Inst/Vol

0/15

Options

5/10

EPS Yr

-29.1%

EPS NY

-15.8%

52W%

7.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +508.8% upside

Quality

6/30

Valuation

16/30

Growth

0/25

Stability

5/10

LT Trend

4/5

Upside

+508.8%

Quality

ProQR Therapeutics N.V.

Sector: Healthcare

Industry: Biotechnology

Employees: 186

ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs. Its lead product candidate, AX-0810, targets na-taurocholate cotransporting polypeptide (NTCP) for the treatment of cholestatic diseases. The company also develops AX-2402, which targets methyl CpG binding protein 2 mutations for Rett syndrome; AX-2911, which targets PNPLA3 for metabolic dysfunction-associated steatohepatitis; and AX-1412, which targets the B4GALT1 gene for cardiovascular diseases. It has a research and collaboration agreement with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.

PRQR

Latest News

—

Caricamento notizie per PRQR…

stock quote shares PRQR – ProQR Therapeutics N.V. Stock Price stock today

news today PRQR – ProQR Therapeutics N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch PRQR – ProQR Therapeutics N.V. yahoo finance google finance

stock history PRQR – ProQR Therapeutics N.V. invest stock market

stock prices PRQR premarket after hours

ticker PRQR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PRQR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y